News items Willem Mulder joins Radboud University Medical Center
15 December 2020

The department of Internal Medicine of the Radboudumc is extremely happy to announce that on January 1st, 2021 Prof. dr. Willem Mulder (1976) will be joining the department, together with some of his researchers. Mulder, who will hold a parttime appointment at Eindhoven University of Technology, will serve as the bridge between the Radboudumc and TU/e. 

After obtaining a master’s degree in chemistry from the Utrecht University and a Ph.D. in biomedical engineering from the Eindhoven University of Technology, Mulder was recruited to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York in 2006. Mulder currently is a tenured professor in the Biomedical Engineering and Imaging Institute where he directs ISMMS’s Nanomedicine Program. This research program focuses on the development and translation of nanomedicine and immuno-imaging approaches for cancer, cardiovascular diseases and organ transplantation. Most notably, Mulder pioneered a disease treatment paradigm involving the regulation of innate immune responses using nanobiologic therapeutics. Mulder is the principal investigator of multiple National Institutes of Health grants.

In addition to his position at Mount Sinai, Mulder held a secondary professor appointment at the Amsterdam UMC from 2012 to 2018, and currently at the Eindhoven University of Technology (TU/e). In 2013, Mulder received a VIDI grant and in 2018 he was awarded a VICI grant, both from the Dutch Research Council (NWO, ZonMW). Mulder has published more than 165 scientific publications in top scientific journals, including Nature Nanotechnology, Nature Reviews Drug Discovery, Nature Biomedical Engineering, Science Translational Medicine, Cell, Immunity, etc. His H-index is 69 and his work has been cited nearly 14.000 times. Mulder is a scientific founder of Trained Therapeutix Discovery, a biotech startup that aims to treat today’s most detrimental diseases with novel nanobiologic therapeutics.

The research of the department of Internal Medicine is focused on inflammation and the immune system in various diseases. Mulder’s research will focus on therapeutically regulating and imaging the immune system with innovative nanotechnology approaches. In addition to the Radboudumc, he will have an appointment at TU/e’s department of biomedical engineering. This will enable an exciting opportunity for collaboration and integration of the strengths of both departments and institutes.

The immuno-oncology revolution and the current COVID-19 pandemic underscore the importance of translational immunology research and biomedical engineering. Radboudumc and TU/e are frontrunners in these respective fields. At Mount Sinai, Mulder built a unique translational research program that integrates nanotechnology, immunology, disease model and in vivo imaging to yield innovative immunotherapy strategies. By moving his research activities to the Netherlands, Mulder will serve as the bridge between the Radboudumc and TU/e. 

More information

Pauline Dekhuijzen

wetenschaps- en persvoorlichter

neem contact op

Related news items

Your heart rate as a thermometer Research Olympic athletes will be followed up during 4Daagse

18 July 2022

Body temperature can be determined from heart rate. This is what research by the Radboudumc among Olympic athletes shows. Athletes can use this method during training to eventually perform better in the heat. The technique is now being further investigated among participants in the 4Daagse.

read more

Do insects help 4Days walkers to recover? a Radboudumc study

7 July 2022

During the first 4Daagse since 2019, Radboudumc is investigating whether walkers will benefit from grounded protein-rich insects. It is known that animal proteins contribute to recovery after exercise, but the researchers want to find out whether proteins from insects can do this just as well.

read more

Grants for research on magnesium deficiency and malaria Vidis for Felix Hol and Jeroen de Baaij

1 July 2022 Radboudumc researchers Jeroen de Baaij and Felix Hol both receive an NWO Vidi grant for their research, respectively on magnesium deficiency in type 2 diabetes and on malaria.  read more

NWO Stevin Prize for expert on Parkinson’s disease Bas Bloem Major scientific prize for societal impact on research into Parkinson's disease

17 June 2022 Neurologist Bas Bloem of Radboudumc receives this year’s Stevin Prize of the Dutch Research Council (NWO). The Stevin Award is the highest distinction in science for a researcher in the Netherlands who has achieved particular success in the area of knowledge utilization for society. read more